BioLife Solutions, Inc. Inventory, Finished Goods, Net of Reserves
BioLife Solutions, Inc. (BLFS) had Inventory, Finished Goods, Net of Reserves of $15.06 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2026-08-06
- 2026-06-30: Inventory, Finished Goods, Net of Reserves $15.06M.
- 2026-03-31: Inventory, Finished Goods, Net of Reserves $14.92M.
- 2025-12-31: Inventory, Finished Goods, Net of Reserves $13.22M.
- 2025-09-30: Inventory, Finished Goods, Net of Reserves $14.68M.
| Period end | Inventory, Finished Goods, Net of Reserves | Inventory, Finished Goods, Net of Reserves as first filed |
|---|---|---|
| 2026-06-30 | $15.06M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $14.92M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $13.22M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $14.68M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $14.27M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $13.23M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $13.16M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $12.81M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $13.07M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $12.35M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $9.02M 10-K · filed 2025-03-03 | $10.11M 10-K · filed 2024-02-29 |
| 2023-09-30 | $12.93M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $12.04M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $10.71M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $8.27M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $10.05M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $10.09M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $8.56M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $6.08M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $8.65M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $9.87M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $7.41M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $6.74M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |